SF
EVH icon

Synovus Financial’s Evolent Health EVH Stock Holding History

Synovus Financial’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-101
Closed -$1K – 911
2020
Q2 		$1K Hold
101
– – ﹤0.01% 1483
2020
Q1 		$1K Hold
101
– – ﹤0.01% 2018
2019
Q4 		$1K Hold
101
– – ﹤0.01% 1484
2019
Q3 		$1K Sell
101
-75
-43% -$538 ﹤0.01% 1420
2019
Q2 		$2K Hold
176
– – ﹤0.01% 1315
2019
Q1 		$2K Hold
176
– – ﹤0.01% 1339
2018
Q4 		$3K Hold
176
– – ﹤0.01% 1266
2018
Q3 		$5K Buy
176
+26
+17% +$620 ﹤0.01% 1230
2018
Q2 		$3K Hold
150
– – ﹤0.01% 1179
2018
Q1 		$2K Buy
+150
New +$2.15K ﹤0.01% 1160
2017
Q2 		– Sell
-150
Closed -$3K – 890
2017
Q1 		$3K Buy
+150
New +$2.88K ﹤0.01% 1045

Other funds holding EVH

EC
Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
CTA
Carillon Tower Advisers St. Petersburg, Florida $16.4B AUM 64.75% 1-Year Est. Return

Synovus Financial's EVH Position: Q3 2020 in Review

Synovus Financial sold out of Evolent Health (EVH) in Q3 2020, closing a stake of 101 shares — an estimated $1K sold.

Synovus Financial first reported a position in EVH in Q1 2017 and held it in 11 quarters. The position peaked at $5K in Q3 2018. 155 funds tracked by Wall St. Rank hold EVH as of Q3 2020.

  • Synovus Financial reported no remaining Evolent Health position as of Q3 2020 after selling out during the quarter.
  • Synovus Financial sold 101 Evolent Health shares in Q3 2020, an estimated $1K.
  • Synovus Financial first reported a position in Evolent Health in Q1 2017 and held it in 11 quarters.
  • Synovus Financial's Evolent Health position peaked at $5K in Q3 2018.
  • 155 funds tracked by Wall St. Rank held Evolent Health as of Q3 2020.

Based on Synovus Financial's 13F filing for Q3 2020, filed 9 Nov 2020.